Log in
Lost password
Become a member for free
Sign up
Sign up
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  Axiall Corp    AXLL

Delayed Quote. Delayed  - 02/05 04:01:31 pm
18.75 USD   -2.60%
02/02 WESTLAKE CHEMIC : Discloses Proposal to Acquire Axiall Corporation f..
01/30 AXIALL : rejects takeover bid by Texas company Westlake Chemical
01/29 AXIALL : rejects $1.4 billion takeover bid from Westlake
Analysis summary4-Traders Strategies 

Axiall Corp : Crossing the trendline gives credit

02/22/2013 | 09:20am
Opinion : Bullish above USD 50.4
Target price : USD 59.5
Stop loss: USD 49.6
Commodity Chemicals

Axiall continues its bullish trend in order to test new highest level.

The company shows strong fundamentals. Firstly, the security is undervalued compared to its peers with an EV/Sales ratio estimated at 0.56 by the Thomson Reuters consensus for this year. Moreover, the consensus revised upward EPS estimates for this year and that let see a great potential for the security on the stock market.

Technically, the security shows a bullish configuration on all time scales. Prices are supported by increasing moving averages. In weekly data, 20-week moving average helps the stock to keep its uptrend and the crossing of the trendline give us another argument.

According to both technical and fundamental elements, it seems opportune to take a long position at the current price. The bullish trend should allow the security to reach the USD 59.5 resistance. If the stock crosses it, a new target price will be set. A stop loss will be placed under the USD 50.4 short term support to avoid a downtrend.

Axiall Corp : Axiall Corp : Crossing the trendline gives credit

© Zonebourse.com 2013

Disclaimer: 4-traders.com is a website published by SURPERFORMANCE SAS. Surperformance or 4-traders.com is not a registered broker-dealer nor a registered investment adviser. You understand that this web site and its content is furnished for your personal, noncommercial, informational purposes only, and that no mention of a particular security in this website constitutes a recommendation to buy, sell, or hold any other security, nor that any particular security, portfolio of securities, transaction or investment strategy is suitable for any specific person. Surperformance and 4-traders.com services will not advise you personally concerning the nature, potential, value or suitability of any particular security, portfolio of securities, transaction, investment strategy or other matter. Information regarding trading and investment as provided by Surperformance professional is not tailored to the investment needs of any specific person. You acknowledge that you are responsible for your own financial decisions and should seek a registered financial agent depending on your own risk tolerance to advise you on your personal trading activities.

Financial Ratios

Size 2015e 2016e
Capitalization 1 323 M$ -
Entreprise Value (EV) 2 391 M$ 2 367 M$
Valuation 2015e 2016e
P/E ratio (Price / EPS) 27,5x
Capitalization / Revenue 0,36x 0,38x
EV / Revenue 0,65x 0,67x
EV / EBITDA 7,07x 6,17x
Yield (DPS / Price) 3,41% 3,41%
Price to book (Price / BVPS) 0,68x 0,71x
Profitability 2015e 2016e
Operating Margin (EBIT / Sales) 2,46% 3,97%
operating Leverage (Delta EBIT / Delta Sales) -2,79x -
Net Margin (Net Profit / Revenue) -21,7% 1,43%
ROA (Net Profit / Asset) 1,45% 2,13%
ROE (Net Profit / Equities) 1,73% 2,76%
Rate of Dividend -5,73% 93,8%
Balance Sheet Analysis 2015e 2016e
CAPEX / Sales   5,00% 7,06%
Cash Flow / Sales 7,27% 8,52%
Capital Intensity (Assets / Sales) -15,0x 0,67x
Financial Leverage (Net Debt / EBITDA) 3,16x 2,72x
Income Statement Evolution
More Financials
EPS Revisions